Literature DB >> 26969602

RETRACTED ARTICLE: MiR-124 Functions as a Tumor Suppressor via Targeting hCLOCK1 in Glioblastoma.

Yichun He1, Conghai Zhao1, Yan Liu1,2, Zhidong He1, Zhihao Zhang1, Yufei Gao3, Jinlan Jiang4.   

Abstract

Entities:  

Year:  2016        PMID： 26969602     DOI： 10.1007/s12035-016-9837-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN： 0893-7648            Impact factor:   5.590


× No keyword cloud information.
  6 in total

1.  Influence of SIRT6 regulation of cellular glycometabolism on radiosensitivity of non-small-cell lung cancer A549 cells.

Authors:  Yong Cai; Zhaoying Sheng; Yun Chen; Jiying Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.

Authors:  Yuexiong Yi; Huirong Li; Qiongying Lv; Kejia Wu; Wenfen Zhang; Juan Zhang; Dingjun Zhu; Qing Liu; Wei Zhang
Journal:  Oncotarget       Date:  2016-11-01

3.  miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2.

Authors:  Shiwei Song; Abul Fajol; Xiankun Tu; Baogang Ren; Songsheng Shi
Journal:  Oncotarget       Date:  2016-10-25

4.  miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.

Authors:  Chunhong Cao; Deguang Sun; Liang Zhang; Lei Song
Journal:  Oncotarget       Date:  2016-11-29

5.  miR‑203 contributes to pre‑eclampsia via inhibition of VEGFA expression.

Authors:  Fulin Liu; Kejia Wu; Wanrong Wu; Yurou Chen; Hanshu Wu; Hui Wang; Wei Zhang
Journal:  Mol Med Rep       Date:  2018-02-02       Impact factor: 2.952

6.  Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy.

Authors:  Ran Kim; Seokyeon Lee; Jihyun Lee; Minji Kim; Won Jung Kim; Hee Won Lee; Min Young Lee; Jongmin Kim; Woochul Chang
Journal:  BMB Rep       Date:  2018-08       Impact factor: 4.778
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.